Carat retains $1.2bn media business in the US
Aegis Media has landed its second Pfizer account in a week, as the pharmaceutical giant has retained Carat to its estimated $1.2bn US media planning and buying business.
The agency held on to the business following a review in September. The agency has worked with Pfizer for 11 years in the US.
The appointment comes after the pharmaceutical giant consolidated all media buying for its Wyeth DTC brands under Carat earlier this year. Intermediary Joanne Davis Consulting handled the review.
Pfizer also works with TargetCast on its media planning and buying account in the US. That relationship is unaffected.
Last week, Aegis-owned Vizeum won Pfizer's £9m media planning and buying business in the UK for its over-the-counter medicine brands.
Vizeum won the pitch against PHD, Maxus and Starcom. Incumbent ZenithOptimedia did not repitch.
This article was first published on campaignlive.co.uk
- Mid Weight Planner - ATL Daniel Marks London £30-£50K + Excellent Benefits, Central London
- PPC Executive - Digital Marketing Agency - Paid Search Ultimate Asset £20000 - £25000 per annum + Amazing Benefits, London
- Senior Strategist - creative comms agency Gabriele Skelton £50000 - £70000 per annum, London
- Freelance Senior Account Manager - urgent The Great & The Good £200 per day , Central London
- Client Director- branding & creative communications agency Gabriele Skelton £50000 - £70000 per annum, London
- Kevin Bacon, Google Glass and Julian Assange: the SXSW weekend in tweets
- International Women's Day: "my gender is irrelevant" says Lisa Thomas
- Omnicom Media Group buys Mobile5
- BBH launches sport division with Lawrence Dallaglio
- IPA's 2014 Women of Tomorrow competition winners revealed
- HSBC launches Hong Kong Rugby Sevens push